A Phase-1/2 Study of Adenovirus-P53 Transduced Dendritic Cell Vaccine in Combination With Indoximod in Metastatic Solid Tumors and Invasive Breast Cancer

Oncotarget - United States
doi 10.18632/oncotarget.24118
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Dendritic Cells Transduced With an Adenovirus Vector Encoding Interleukin-12 Are a Potent Vaccine for Invasive Pulmonary Aspergillosis

Genes and Immunity
ImmunologyGenetics
2005English

A Phase II Trial of Erlotinib in Combination With Bevacizumab in Patients With Metastatic Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2008English

Combination Chemotherapy in Metastatic Breast Cancer

BMJ
1977English

A Phase I Study of BMS-690514 in Japanese Patients With Advanced or Metastatic Solid Tumors

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2012English

Combination Chemotherapy in Metastatic Breast Cancer

InPharma
1977English

A Phase II, Randomized, Multicenter Study Evaluating the Combination of Lapatinib and Vinorelbine in Women With ErbB2 Overexpressing Metastatic Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2014English

A Phase 1 Study of Oral Ridaforolimus in Pediatric Patients With Advanced Solid Tumors

Oncotarget
Oncology
2016English

Fusions of Breast Carcinoma and Dendritic Cells as a Vaccine for the Treatment of Metastatic Breast Cancer. Addendum

2009English

Immunotherapeutic Cell-Based Vaccine to Combat Metastatic Breast Cancer

2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy